[1] DIETMAR SPRINGER. Identification of cytochrome p450 enzymes involved in the metabolism of 4’-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes.[J]. Drug Metabolism and Disposition, 2003, 31 8: 979-982. DOI:
10.1124/dmd.31.8.979[2] RURI KIKURA-HANAJIRI Yukihiro G Nahoko Uchiyama. Survey of current trends in the abuse of psychotropic substances and plants in Japan[J]. Legal Medicine, 2011, 13 3: Pages 109-115. DOI:
10.1016/j.legalmed.2011.02.003[3] DR SIMON D. BRANDT. Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones[J]. Drug Testing and Analysis, 2010, 3 9: 569-575. DOI:
10.1002/dta.204[4] DIETMAR SPRINGER Hans H M Giselher Fritschi. Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry[J]. Journal of Chromatography B, 2003, 796 2: Pages 253-266. DOI:
10.1016/j.jchromb.2003.07.008[5] STEPHANIE CARNES. Comparison of ultra high performance supercritical fluid chromatography, ultra high performance liquid chromatography, and gas chromatography for the separation of synthetic cathinones[J]. Journal of separation science, 2017, 40 17: 3545-3556. DOI:
10.1002/jssc.201700349